EVALUATION OF CLAZAKIZUMAB (ANTI-IL-6) FOR TREATMENT OF KIDNEY TRANSPLANT RECIPIENTS WITH CHRONIC & ACTIVE ANTIBODY MEDIATED REJECTION

被引：0
|
作者：
Jordan, Stanley [1 ]
Ammerman, Noriko [1 ]
Toyoda, Mieko [1 ]
Huang, Edmund [1 ]
Nast, Cynthia [1 ]
Peng, Alice [1 ]
Sethi, Supreet [1 ]
Najjar, Reiad [1 ]
Kim, Irene [1 ]
Lim, Kathlyn [1 ]
Choi, Jua [1 ]
Vo, Ashley [1 ]
机构：
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
来源：
TRANSPLANT INTERNATIONAL | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
LBA003
引用
收藏
页码：400 / 401
页数：2
相关论文
共 50 条
  • [1] A Randomized Clinical Trial of Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Kidney Transplant Rejection
    Doberer, Konstantin
    Duerr, Michael
    Halloran, Philip F.
    Eskandary, Farsad
    Budde, Klemens
    Regele, Heinz
    Reeve, Jeff
    Borski, Anita
    Kozakowski, Nicolas
    Reindl-Schwaighofer, Roman
    Waiser, Johannes
    Lachmann, Nils
    Schranz, Sabine
    Firbas, Christa
    Muehlbacher, Jakob
    Gelbenegger, Georg
    Perkmann, Thomas
    Wahrmann, Markus
    Kainz, Alexander
    Ristl, Robin
    Halleck, Fabian
    Bond, Gregor
    Chong, Edward
    Jilma, Bernd
    Boehmig, Georg A.
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (03): : 708 - 722
  • [2] CLAZAKIZUMAB (ANTI-IL-6 MONOCLONAL) TREATMENT OF PATIENTS WITH CHRONIC & ACTIVE ANTIBODY-MEDIATED REJECTION POST-KIDNEY TRANSPLANTATION (NCT03380377)
    Jordan, Stanley
    Ammerman, Noriko
    Toyoda, Mieko
    Ge, Shili
    Huang, Edmund
    Peng, Alice
    Sethi, Supreet
    Najjar, Reiad
    Ortiz, Edwin
    Chu, Maggie
    De Guzman, Abner
    Kim, Irene
    Lim, Kathlyn
    Choi, Jua
    Vo, Ashley A.
    [J]. TRANSPLANTATION, 2020, 104 (09) : S67 - S68
  • [3] Clazakizumab for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Transplant Recipients: Phase 3 IMAGINE Study Design
    Nickerson, P.
    Boehmig, G.
    Chadban, S.
    Kumar, D.
    Mannon, R. B.
    Van Gelder, T.
    Adler, S.
    Chong, E.
    Djamali, A.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2021, 21 : 737 - 737
  • [4] Monitoring Inflammatory Cytokine Levels in Kidney Transplant Patients (KTx Pts) with Chronic Antibody Mediated Rejection (cABMR) Treated with Clazakizumab (CLZ, Humanized Anti-IL-6 Monoclonal Antibody).
    Ge, S.
    Petrosyan, A.
    Chu, M.
    Ammerman, N.
    Vo, A.
    Jordan, S. C.
    Zhang, X.
    Toyoda, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2019, 19 : 661 - 661
  • [5] Evaluation of Clazakizumab (Anti-Interleukin-6) in Patients With Treatment-Resistant Chronic Active Antibody-Mediated Rejection of Kidney Allografts
    Jordan, Stanley C.
    Ammerman, Noriko
    Choi, Jua
    Huang, Edmund
    Najjar, Reiad
    Peng, Alice
    Sethi, Supreet
    Sandhu, Rana
    Atienza, Janet
    Toyoda, Mieko
    Ge, Shili
    Lim, Kathlyn
    Gillespie, Matthew
    Zhang, Xiaohai
    Haas, Mark
    Vo, Ashley
    [J]. KIDNEY INTERNATIONAL REPORTS, 2022, 7 (04): : 720 - 731
  • [6] Anti-IL-6 Antibody Clazakizumab in Late Antibody-Mediated Rejection - Molecular Rebound Phenomena Under IL-6 Blockade?
    Borski, A.
    Haindl, S.
    Duerr, M.
    Budde, K.
    Schranz, S.
    Eskandary, F. A.
    Doberer, K.
    Halloran, P. F.
    Chong, E.
    Jilma, B.
    Boehmig, G. A.
    Wahrmann, M.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2020, 20 : 853 - 853
  • [7] ACUTE AND CHRONIC ACTIVE ANTIBODY MEDIATED REJECTION IN KIDNEY TRANSPLANT RECIPIENTS: PROGNOSIS AND TREATMENT
    Yilmaz, Vural Taner
    Kocak, Huseyin
    Suleymanlar, Gultekin
    Cetinkaya, Ramazan
    Akkaya, Bahar
    Akbas, Halide
    Koksoy, Sadi
    Kisaoglu, Abdullah
    Aydinli, Bulent
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 527 - 527
  • [8] Tocilizumab for treatment of chronic active antibody-mediated rejection in kidney transplant recipients
    Boonpheng, Boonphiphop
    De Castro, Iris Camille C.
    Ng, Yue-Harn
    Blosser, Christopher
    Bakthavatsalam, Ramasamy
    Gimferrer, Idoia
    Smith, Kelly
    Leca, Nicolae
    [J]. CLINICAL TRANSPLANTATION, 2023, 37 (05)
  • [9] ANTI-IL-6 ANTIBODY CLAZAKIZUMAB IN LATE ANTIBODY-MEDIATED REJECTION - MOLECULAR REBOUND PHENOMENA UNDER IL-6 BLOCKADE?
    Borski, Anita
    Haindl, Susanne
    Durr, Michael
    Budde, Klemens
    Schranz, Sabine
    Eskandary, Farsad A.
    Doberer, Konstantin
    Halloran, Philip F.
    Chong, Edward
    Jilma, Bernd
    Bohmig, Georg A.
    Wahrmann, Markus
    [J]. TRANSPLANTATION, 2020, 104 (09) : S67 - S67
  • [10] Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
    Nickerson, Peter W.
    Boehmig, Georg A.
    Chadban, Steve
    Kumar, Deepali
    Mannon, Roslyn B.
    van Gelder, Teun
    Lee, James C.
    Adler, Scott
    Chong, Edward
    Djamali, Arjang
    [J]. TRIALS, 2022, 23 (01)
12345